Onkológia 5/2021
New trends in stem cell transplantation in lymphoproliferatives disorders
New drugs changed in the last 10 years biological behaviour of lymphoproliferative disorders (LPD), most of them become of chronical disorders. This new trends changed or in the nearest time change indication for stem cell transplantation (SCT). Better supportive treatment and knowledge of the functioning of nonmyeloablative regimen increased age of the transplanted patients. This review is focusing on the most important changes in SCT of LPD.
Keywords: stem cell transplantation, lymphoma, nonmyeloablative regimen, new drugs
